IL78017A - Sustained release tablets of theophylline - Google Patents

Sustained release tablets of theophylline

Info

Publication number
IL78017A
IL78017A IL78017A IL7801786A IL78017A IL 78017 A IL78017 A IL 78017A IL 78017 A IL78017 A IL 78017A IL 7801786 A IL7801786 A IL 7801786A IL 78017 A IL78017 A IL 78017A
Authority
IL
Israel
Prior art keywords
theophylline
sustained release
release tablets
relates
tablet
Prior art date
Application number
IL78017A
Other languages
English (en)
Other versions
IL78017A0 (en
Inventor
Friedman Michael
Bialer Meir
Ziad Hussein
Original Assignee
Yissum Res Dev Co
Univ Jerusalem Hebrew
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Univ Jerusalem Hebrew filed Critical Yissum Res Dev Co
Priority to IL78017A priority Critical patent/IL78017A/xx
Publication of IL78017A0 publication Critical patent/IL78017A0/xx
Priority to CA000522807A priority patent/CA1276107C/en
Priority to JP61270831A priority patent/JPH06104625B2/ja
Priority to AT86115815T priority patent/ATE59960T1/de
Priority to DE8686115815T priority patent/DE3676997D1/de
Priority to EP86115815A priority patent/EP0235363B1/de
Priority to US06/938,265 priority patent/US4795645A/en
Priority to ZA876498A priority patent/ZA876498B/xx
Publication of IL78017A publication Critical patent/IL78017A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL78017A 1986-03-03 1986-03-03 Sustained release tablets of theophylline IL78017A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL78017A IL78017A (en) 1986-03-03 1986-03-03 Sustained release tablets of theophylline
CA000522807A CA1276107C (en) 1986-03-03 1986-11-12 Sustained release tablets of theophylline
JP61270831A JPH06104625B2 (ja) 1986-03-03 1986-11-13 徐放性錠剤
AT86115815T ATE59960T1 (de) 1986-03-03 1986-11-14 Theophyllintabletten mit verzoegerter freigabe.
DE8686115815T DE3676997D1 (de) 1986-03-03 1986-11-14 Theophyllintabletten mit verzoegerter freigabe.
EP86115815A EP0235363B1 (de) 1986-03-03 1986-11-14 Theophyllintabletten mit verzögerter Freigabe
US06/938,265 US4795645A (en) 1986-03-03 1986-11-25 Sustained release tablets of theophylline
ZA876498A ZA876498B (en) 1986-03-03 1987-08-31 Sustained release tablets of theophylline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL78017A IL78017A (en) 1986-03-03 1986-03-03 Sustained release tablets of theophylline

Publications (2)

Publication Number Publication Date
IL78017A0 IL78017A0 (en) 1986-07-31
IL78017A true IL78017A (en) 1989-06-30

Family

ID=11056558

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78017A IL78017A (en) 1986-03-03 1986-03-03 Sustained release tablets of theophylline

Country Status (7)

Country Link
US (1) US4795645A (de)
EP (1) EP0235363B1 (de)
JP (1) JPH06104625B2 (de)
AT (1) ATE59960T1 (de)
CA (1) CA1276107C (de)
DE (1) DE3676997D1 (de)
IL (1) IL78017A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
FR2650502B1 (fr) * 1989-08-07 1994-05-27 Delagrange Laboratoires Nouvelle forme galenique orale ameliorant la biodisponibilite
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20110268666A1 (en) * 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
WO2011132157A1 (en) * 2010-04-22 2011-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Oral sustained release formulation of huperzine a
CN116966157B (zh) * 2023-09-22 2024-02-09 山东则正医药技术有限公司 一种茶碱缓释片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (de) * 1961-01-31
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4002756A (en) * 1974-04-22 1977-01-11 Interx Research Corporation Useful pro-drug forms of theophylline
US4147167A (en) * 1976-08-05 1979-04-03 Horst R. Hickmann Ophthalmic prosthesis implant instrument
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
DE3104815C2 (de) * 1980-02-13 1983-07-07 Japan Atomic Energy Research Institute, Tokyo Verfahren zur Herstellung eines Verbundstoffs mit Langzeit-Freigabe
JPS6042205B2 (ja) * 1980-12-22 1985-09-20 日本原子力研究所 徐放性複合体の製造方法
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules

Also Published As

Publication number Publication date
EP0235363A2 (de) 1987-09-09
JPS62207217A (ja) 1987-09-11
DE3676997D1 (de) 1991-02-21
CA1276107C (en) 1990-11-13
JPH06104625B2 (ja) 1994-12-21
ATE59960T1 (de) 1991-02-15
EP0235363A3 (en) 1987-11-19
US4795645A (en) 1989-01-03
IL78017A0 (en) 1986-07-31
EP0235363B1 (de) 1991-01-16

Similar Documents

Publication Publication Date Title
IL78017A0 (en) Sustained release tablets of theophylline
CS410191A3 (en) Benzimidazoles, process of their preparation and medicaments comprising said compounds
EP0336205A3 (en) Process for the preparation of isocyanuratepolyisocyanates, the compounds obtained according to this process and their use
HUT41642A (en) Process for producing tablets of regulated dissolution of the active agents
AU6952687A (en) Process for the preparation of granules containing an active substance and to the use therefor as speckles for treating substrates
DE2960292D1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
AU8375682A (en) Nonapeptide for treatment of drug withdrawal symptoms
HUT48269A (en) Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them
PT84899A (en) Process for the preparation of pharmaceutical compositions containing ?-phenyl-1,2-benzisoselenazol-3(2h)-one for the treatment of skin diseases
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
HUT49494A (en) Process for producing active component of pharmaceutical compositions
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
DE2963990D1 (en) Analgesic tablet and process for its preparation
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
EP0365868A3 (en) Process to separate glycolipides from a mixture of lipids, and use of the fractions obtained
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
HUT52958A (en) Process for production of medical compositions assuring the constant release of the active substance
ZA837332B (en) Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form
ZA877334B (en) Process for preparing soluble and/or splitable tablets and tablets thus obtained
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
PH17503A (en) A process for the preparation of 1,3,7-trialkyl-xanthines and 1-isopropyl-and 1-isobutyl-3,7-dimethyl xanteines as medicaments
HUT49807A (en) Process for production of medical compositions and the active substance
IL82937A (en) 4-benzoyloxy-3-pyrrolin-2-on-1-yl acetamide,process for the preparation thereof and the use thereof
GB2164556B (en) Sustained release pharmaceutical tablet of theophylline and production process therefor

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed